Depreciation of Skye Bioscience, Inc. from 31 Jan 2013 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Skye Bioscience, Inc. annual and quarterly Depreciation in USD history and change rate from 31 Jan 2013 to 31 Dec 2025.
  • Skye Bioscience, Inc. Depreciation for the quarter ending 31 Mar 2024 was $27,560, a 17% decline year-over-year.
  • Skye Bioscience, Inc. annual Depreciation for 2025 was $540,135, a 165% increase from 2024.
  • Skye Bioscience, Inc. annual Depreciation for 2024 was $203,757, a 308% increase from 2023.
  • Skye Bioscience, Inc. annual Depreciation for 2023 was $49,909, a 57% decline from 2022.
Source SEC data
View on sec.gov
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)

Skye Bioscience, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $540,135 +$336,378 +165% 01 Jan 2025 31 Dec 2025 10-K 10 Mar 2026 2025 FY
2024 $203,757 +$153,848 +308% 01 Jan 2024 31 Dec 2024 10-K 10 Mar 2026 2025 FY
2023 $49,909 -$65,089 -57% 01 Jan 2023 31 Dec 2023 10-K 20 Mar 2025 2024 FY
2022 $114,998 +$80,867 +237% 01 Jan 2022 31 Dec 2022 10-K 22 Mar 2024 2023 FY
2021 $34,131 +$32,259 +1723% 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023 2022 FY
2020 $1,872 +$410 +28% 01 Jan 2020 31 Dec 2020 10-K 28 Mar 2022 2021 FY
2019 $1,462 -$82 -5.3% 01 Jan 2019 31 Dec 2019 10-K 02 Mar 2021 2020 FY
2018 $1,544 -$6,495 -81% 01 Jan 2018 31 Dec 2018 10-K 23 Mar 2020 2019 FY
2017 $8,039 -$6,877 -46% 01 Jan 2017 31 Dec 2017 10-K 14 Mar 2019 2018 FY
2016 $14,916 +$4,963 +50% 01 Jan 2016 31 Dec 2016 10-K 19 Mar 2018 2017 FY
2015 $9,953 +$8,045 +422% 01 Jan 2015 31 Dec 2015 10-K 10 Mar 2017 2016 FY
2014 $1,908 -$8,964 -82% 01 Jan 2014 31 Dec 2014 10-K 21 Mar 2016 2015 FY
2013 $10,872 01 Nov 2012 31 Oct 2013 10-K 27 Jan 2014 2013 FY

Skye Bioscience, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $27,560 -$5,614 -17% 01 Jan 2024 31 Mar 2024 10-Q 10 May 2024 2024 Q1
Q1 2023 $33,174 +$6,196 +23% 01 Jan 2023 31 Mar 2023 10-Q 10 May 2024 2024 Q1
Q1 2022 $26,978 +$26,040 +2776% 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023 2023 Q1
Q1 2021 $938 +$573 +157% 01 Jan 2021 31 Mar 2021 10-Q 06 May 2022 2022 Q1
Q1 2020 $365 -$1 -0.27% 01 Jan 2020 31 Mar 2020 10-Q 07 May 2021 2021 Q1
Q1 2019 $366 +$35 +11% 01 Jan 2019 31 Mar 2019 10-Q 08 May 2020 2020 Q1
Q1 2018 $331 -$2,097 -86% 01 Jan 2018 31 Mar 2018 10-Q 10 May 2019 2019 Q1
Q1 2017 $2,428 -$1,273 -34% 01 Jan 2017 31 Mar 2017 10-Q 15 May 2018 2018 Q1
Q1 2016 $3,701 +$1,388 +60% 01 Jan 2016 31 Mar 2016 10-Q 12 May 2017 2017 Q1
Q1 2015 $2,313 01 Jan 2015 31 Mar 2015 10-Q 13 May 2016 2016 Q1
Q4 2013 $2,374 +$1,583 +200% 01 Nov 2013 31 Jan 2014 10-Q 17 Mar 2014 2014 Q1
Q4 2012 $791 01 Nov 2012 31 Jan 2013 10-Q 17 Mar 2014 2014 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.